Intricate link between siderophore secretion and drug efflux in Mycobacterium tuberculosis
Antimicrobial Agents and Chemotherapy · 18.10.2023 · 67 (10)
DOI: 10.1128/aac.01629-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 18.10.2023. Verfasst von Virginia Meikle und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Alabama at Birmingham , Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health.
Abstract (Originalsprache)
Drug-resistant Mycobacterium tuberculosis is a worldwide health-care problem rendering current tuberculosis (TB) drugs ineffective. Drug efflux is an important mechanism in bacterial drug resistance. The MmpL4 and MmpL5 transporters form functionally redundant complexes with their associated MmpS4 and MmpS5 proteins and constitute the inner membrane components of an essential siderophore secretion system of M. tuberculosis . Inactivating siderophore secretion is toxic for M. tuberculosis due to self-poisoning at low-iron conditions and leads to a strong virulence defect in mice. In this study, we show that M. tuberculosis mutants lacking components of the MmpS4-MmpL4 and MmpS5-MmpL5 systems are more susceptible to bedaquiline, clofazimine, and rifabutin, important drugs for treatment of drug-resistant TB. While genetic deletion experiments revealed similar functions of the MmpL4 and MmpL5 transporters in siderophore and drug secretion, complementation experiments indicated that the MmpS4-MmpL4 proteins alone are not sufficient to restore drug efflux in an M. tuberculosis mutant lacking both operons, in contrast to MmpS5-MmpL5. Importantly, an M. tuberculosis mutant lacking the recently discovered periplasmic Rv0455c protein, which is also essential for siderophore secretion, is more susceptible to the same drugs. These results reveal a promising target for the development of dual-function TB drugs, which might poison M. tuberculosis by blocking siderophore secretion and synergize with other drugs by impairing drug efflux.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, University of Alabama at Birmingham , Birmingham, Alabama, USA.
ORCID-Profile: Michael Niederweis
Förderung
- NIAID NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Meikle, V., Zhang, L., & Niederweis, M. (2023). Intricate link between siderophore secretion and drug efflux in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 67(10). https://doi.org/10.1128/aac.01629-22
Vancouver
Meikle V, Zhang L, Niederweis M. Intricate link between siderophore secretion and drug efflux in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 2023;67(10). doi:10.1128/aac.01629-22
BibTeX
@article{Meikle2023,
author = {Meikle, Virginia and Zhang, Lei and Niederweis, Michael},
title = {Intricate link between siderophore secretion and drug efflux in Mycobacterium tuberculosis},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
volume = {67},
number = {10},
doi = {10.1128/aac.01629-22}
}
EUVIMED